Shandong Shanda Wit Science and Technology Co Ltd (000915) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.152x

Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has a cash flow conversion efficiency ratio of 0.152x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥620.45 Million ≈ $90.79 Million USD) by net assets (CN¥4.08 Billion ≈ $596.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shandong Shanda Wit Science and Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000915 current and long-term liabilities for a breakdown of total debt and financial obligations.

Shandong Shanda Wit Science and Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Everlight Electronics Co Ltd
TW:2393
0.030x
Star Petroleum Refining Co Ltd
BK:SPRC
-0.073x
CBL & Associates Properties Inc
NYSE:CBL
0.204x
Soulbrain Holdings Co. Ltd
KQ:036830
0.005x
Banco Patagonia
BA:BPAT
-0.006x
Graincorp Ltd
AU:GNC
0.239x
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
0.042x
Nitratos de Chile SA
SN:NITRATOS
0.085x

Annual Cash Flow Conversion Efficiency for Shandong Shanda Wit Science and Technology Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Shanda Wit Science and Technology Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shandong Shanda Wit Science and Technolo.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.41 Billion
≈ $645.68 Million
CN¥929.61 Million
≈ $136.03 Million
0.211x -19.35%
2023-12-31 CN¥4.50 Billion
≈ $658.00 Million
CN¥1.17 Billion
≈ $171.89 Million
0.261x -11.32%
2022-12-31 CN¥4.06 Billion
≈ $594.32 Million
CN¥1.20 Billion
≈ $175.07 Million
0.295x +32.48%
2021-12-31 CN¥3.40 Billion
≈ $497.44 Million
CN¥755.85 Million
≈ $110.61 Million
0.222x -11.27%
2020-12-31 CN¥2.94 Billion
≈ $429.52 Million
CN¥735.55 Million
≈ $107.63 Million
0.251x +164.15%
2019-12-31 CN¥2.57 Billion
≈ $375.65 Million
CN¥243.54 Million
≈ $35.64 Million
0.095x -58.77%
2018-12-31 CN¥2.34 Billion
≈ $342.53 Million
CN¥538.56 Million
≈ $78.81 Million
0.230x +19.80%
2017-12-31 CN¥2.22 Billion
≈ $324.66 Million
CN¥426.11 Million
≈ $62.35 Million
0.192x -25.26%
2016-12-31 CN¥1.95 Billion
≈ $285.25 Million
CN¥500.91 Million
≈ $73.30 Million
0.257x +48.70%
2015-12-31 CN¥1.68 Billion
≈ $245.77 Million
CN¥290.24 Million
≈ $42.47 Million
0.173x -5.97%
2014-12-31 CN¥1.48 Billion
≈ $216.90 Million
CN¥272.41 Million
≈ $39.86 Million
0.184x -1.32%
2013-12-31 CN¥1.16 Billion
≈ $169.76 Million
CN¥216.05 Million
≈ $31.62 Million
0.186x +7.77%
2012-12-31 CN¥946.05 Million
≈ $138.44 Million
CN¥163.48 Million
≈ $23.92 Million
0.173x -4.43%
2011-12-31 CN¥769.24 Million
≈ $112.56 Million
CN¥139.09 Million
≈ $20.35 Million
0.181x -38.03%
2010-12-31 CN¥649.52 Million
≈ $95.05 Million
CN¥189.51 Million
≈ $27.73 Million
0.292x +18.77%
2009-12-31 CN¥526.71 Million
≈ $77.07 Million
CN¥129.39 Million
≈ $18.93 Million
0.246x +16.04%
2008-12-31 CN¥443.06 Million
≈ $64.83 Million
CN¥93.80 Million
≈ $13.73 Million
0.212x -17.66%
2007-12-31 CN¥393.55 Million
≈ $57.59 Million
CN¥101.20 Million
≈ $14.81 Million
0.257x +79.88%
2006-12-31 CN¥363.40 Million
≈ $53.18 Million
CN¥51.95 Million
≈ $7.60 Million
0.143x -22.52%
2005-12-31 CN¥343.51 Million
≈ $50.27 Million
CN¥63.38 Million
≈ $9.27 Million
0.184x +87.65%
2004-12-31 CN¥310.43 Million
≈ $45.43 Million
CN¥30.52 Million
≈ $4.47 Million
0.098x +1111.11%
2003-12-31 CN¥299.64 Million
≈ $43.85 Million
CN¥2.43 Million
≈ $355.95K
0.008x +112.45%
2002-12-31 CN¥253.39 Million
≈ $37.08 Million
CN¥-16.53 Million
≈ $-2.42 Million
-0.065x -11925.11%
2001-12-31 CN¥245.49 Million
≈ $35.92 Million
CN¥-133.16K
≈ $-19.49K
-0.001x +99.84%
2000-12-31 CN¥258.69 Million
≈ $37.85 Million
CN¥-90.48 Million
≈ $-13.24 Million
-0.350x -303.55%
1999-12-31 CN¥262.99 Million
≈ $38.48 Million
CN¥45.19 Million
≈ $6.61 Million
0.172x -12.93%
1998-12-31 CN¥122.61 Million
≈ $17.94 Million
CN¥24.20 Million
≈ $3.54 Million
0.197x --

About Shandong Shanda Wit Science and Technology Co Ltd

SHE:000915 China Drug Manufacturers - Specialty & Generic
Market Cap
$993.04 Million
CN¥6.79 Billion CNY
Market Cap Rank
#9152 Global
#2459 in China
Share Price
CN¥28.96
Change (1 day)
+1.12%
52-Week Range
CN¥28.10 - CN¥35.60
All Time High
CN¥45.34
About

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more